RASL10A

Across TCGA pan-cancer cohorts, RASL10A mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RASL10A data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RASL10A mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RASL10A expression acts as an unfavorable survival marker.

UCEC are the cancer types where RASL10A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.679	1.000	.022	4	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RASL10A–UCEC (OS)

Open the UCEC breakdown →